Submission Details
| 510(k) Number | K100980 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 08, 2010 |
| Decision Date | June 01, 2011 |
| Days to Decision | 419 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
K100980 is an FDA 510(k) clearance for the INVADER FACTOR V, a Test, Factor V Leiden Mutations, Genomic Dna Pcr (Class II — Special Controls, product code NPQ), submitted by Hologic, Inc. (Marlborough, US). The FDA issued a Cleared decision on June 1, 2011, 419 days after receiving the submission on April 8, 2010. This device falls under the Pathology review panel. Regulated under 21 CFR 864.7280.
| 510(k) Number | K100980 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 08, 2010 |
| Decision Date | June 01, 2011 |
| Days to Decision | 419 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
| Product Code | NPQ — Test, Factor V Leiden Mutations, Genomic Dna Pcr |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7280 |
| Definition | In Vitro Diagnostic Test To Detect The Factor V Leiden Mutation In Genomic Dna, As An Aid To Diagnosis In The Evaluation Of Patients With Suspected Thrombophilia. |